US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.980
  • -0.020-1.00%
Trading Apr 19 13:42 ET
224.73MMarket Cap-782P/E (TTM)

About Coherus BioSciences Company

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Company Profile

SymbolCHRS
Company NameCoherus BioSciences
Listing DateNov 6, 2014
Issue Price13.50
Founded2010
CEOMr. Dennis M. Lanfear
MarketNASDAQ
Employees306
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address333 Twin Dolphin Drive,Suite 600
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94065
Phone1-650-649-3530
Websitehttp://www.coherus.com

Company Executives

  • Name
  • Position
  • Salary
  • Dennis M. Lanfear
  • President, Chief Executive Officer and Chairman of the Board
  • 5.90M
  • Paul Reider
  • Chief Commercial Officer
  • 1.93M
  • Bryan J. McMichael
  • Interim Chief Financial Officer, Executive Vice President, Accounting, Corporate Controller and Principal Accounting Officer
  • 1.07M
  • Dr. Michael Ryan, Pharm.D.
  • Director
  • 173.61K
  • Georgia L. Erbez
  • Director
  • --
  • Mark D. Stolper
  • Independent Director
  • 198.69K
  • Charles Newton
  • Independent Director
  • 188.69K
  • Dr. Jill O’Donnell-Tormey
  • Independent Director
  • 183.69K
  • Mats L. Wahlstrom
  • Lead Independent Director
  • 228.69K
  • Kimberly J. Commins-Tzoumakas
  • Independent Director
  • 193.69K
  • Dr. Lee N. Newcomer, M.D.
  • Independent Director
  • 186.19K
  • Ali J. Satvat
  • Independent Director
  • 65.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg